PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NARI vs. IMVT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


NARIIMVT
YTD Return-20.98%-30.52%
1Y Return-8.67%-10.76%
3Y Return (Ann)-18.03%50.96%
Sharpe Ratio-0.07-0.22
Sortino Ratio0.270.01
Omega Ratio1.041.00
Calmar Ratio-0.05-0.20
Martin Ratio-0.14-0.36
Ulcer Index26.96%28.84%
Daily Std Dev51.55%47.61%
Max Drawdown-70.53%-93.59%
Current Drawdown-59.26%-44.47%

Fundamentals


NARIIMVT
Market Cap$3.00B$4.30B
EPS-$1.35-$2.21
Total Revenue (TTM)$574.50M$1.50M
Gross Profit (TTM)$494.08M$1.30M
EBITDA (TTM)-$19.90M-$335.58M

Correlation

-0.50.00.51.00.2

The correlation between NARI and IMVT is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

NARI vs. IMVT - Performance Comparison

In the year-to-date period, NARI achieves a -20.98% return, which is significantly higher than IMVT's -30.52% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%30.00%JuneJulyAugustSeptemberOctoberNovember
12.75%
-3.97%
NARI
IMVT

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NARI vs. IMVT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Inari Medical, Inc. (NARI) and Immunovant, Inc. (IMVT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NARI
Sharpe ratio
The chart of Sharpe ratio for NARI, currently valued at -0.07, compared to the broader market-4.00-2.000.002.004.00-0.07
Sortino ratio
The chart of Sortino ratio for NARI, currently valued at 0.27, compared to the broader market-4.00-2.000.002.004.006.000.27
Omega ratio
The chart of Omega ratio for NARI, currently valued at 1.04, compared to the broader market0.501.001.502.001.04
Calmar ratio
The chart of Calmar ratio for NARI, currently valued at -0.05, compared to the broader market0.002.004.006.00-0.05
Martin ratio
The chart of Martin ratio for NARI, currently valued at -0.14, compared to the broader market0.0010.0020.0030.00-0.14
IMVT
Sharpe ratio
The chart of Sharpe ratio for IMVT, currently valued at -0.22, compared to the broader market-4.00-2.000.002.004.00-0.22
Sortino ratio
The chart of Sortino ratio for IMVT, currently valued at 0.01, compared to the broader market-4.00-2.000.002.004.006.000.01
Omega ratio
The chart of Omega ratio for IMVT, currently valued at 1.00, compared to the broader market0.501.001.502.001.00
Calmar ratio
The chart of Calmar ratio for IMVT, currently valued at -0.20, compared to the broader market0.002.004.006.00-0.20
Martin ratio
The chart of Martin ratio for IMVT, currently valued at -0.36, compared to the broader market0.0010.0020.0030.00-0.36

NARI vs. IMVT - Sharpe Ratio Comparison

The current NARI Sharpe Ratio is -0.07, which is higher than the IMVT Sharpe Ratio of -0.22. The chart below compares the historical Sharpe Ratios of NARI and IMVT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.50JuneJulyAugustSeptemberOctoberNovember
-0.07
-0.22
NARI
IMVT

Dividends

NARI vs. IMVT - Dividend Comparison

Neither NARI nor IMVT has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

NARI vs. IMVT - Drawdown Comparison

The maximum NARI drawdown since its inception was -70.53%, smaller than the maximum IMVT drawdown of -93.59%. Use the drawdown chart below to compare losses from any high point for NARI and IMVT. For additional features, visit the drawdowns tool.


-70.00%-65.00%-60.00%-55.00%-50.00%-45.00%-40.00%-35.00%JuneJulyAugustSeptemberOctoberNovember
-59.26%
-44.47%
NARI
IMVT

Volatility

NARI vs. IMVT - Volatility Comparison

Inari Medical, Inc. (NARI) has a higher volatility of 19.32% compared to Immunovant, Inc. (IMVT) at 11.42%. This indicates that NARI's price experiences larger fluctuations and is considered to be riskier than IMVT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


8.00%10.00%12.00%14.00%16.00%18.00%20.00%JuneJulyAugustSeptemberOctoberNovember
19.32%
11.42%
NARI
IMVT

Financials

NARI vs. IMVT - Financials Comparison

This section allows you to compare key financial metrics between Inari Medical, Inc. and Immunovant, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items